About Company
Calcilytix Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for rare diseases, particularly those related to calcium signaling. The company is dedicated to advancing therapies for conditions caused by genetic mutations that disrupt calcium homeostasis, such as hypercalcemia. By leveraging cutting-edge science, Calcilytix aims to bring forward novel therapies that can improve the quality of life for patients with rare and complex disorders. The company's goal is to address unmet medical needs through targeted drug discovery, clinical development, and patient-centric care.